Intranasal Naloxone Product Approved by FDA
The Carlat Addiction Treatment Report, Volume 4, Number 1, January 2016
https://www.thecarlatreport.com/newsletter-issue/catrv4n1/
Issue Links: Learning Objectives | Editorial Information
Topics: Addiction | Substance Abuse
Talia Puzantian, PharmD, BCPP
The opioid antagonist, naloxone, was first approved for opioid overdose treatment in 1971 and is available as an inexpensive injectable generic. In recent years, emergency responders have been using more easily administered intranasal version of naloxone.
You can't view details of this content, please login or buy subscription here
Talia Puzantian, PharmD, BCPP
Clinical psychopharmacology consultant, www.taliapuzantian.com
Dr. Puzantian has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.